Case Report: Two Rare Cases of Complete Metabolic Response to Crizotinib in Patients With Rearranged ROS1 and ALK Metastatic Non-small Lung Cancer

Overview of attention for article published in Frontiers in Medicine, September 2021

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (65th percentile)
Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

twitter: 4 X users

Readers on

mendeley: 1 Mendeley

Summary X

So far, Altmetric has seen 5 X posts from 4 X users, with an upper bound of 4,244 followers.

Case Report: Two Rare Cases of Complete Metabolic Response to Crizotinib in Patients With Rearranged ROS1 and ALK Metastatic Non-small Lung Cancer #lymphoma #lymsm https://t.co/YZigO6ITy1

19 Oct 2021

Reply Repost Favourite

Case Report: Two Rare Cases of Complete Metabolic Response to Crizotinib in Patients With Rearranged ROS1 and ALK Metastatic Non-small Lung Cancer #lymphoma #lymsm https://t.co/8yVQkGRVri

18 Oct 2021

Reply Repost Favourite

RT @AMRANEKarim6: Two rare cases of complete metabolic response to Crizotinib in patients with rearranged ROS-1 and ALK metastatic non-smal…

10 Sep 2021

Reply Repost Favourite

RT @AMRANEKarim6: Two rare cases of complete metabolic response to Crizotinib in patients with rearranged ROS-1 and ALK metastatic non-smal…

10 Sep 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.